Characterization of a Novel Mouse Platelet Transfusion Model

Area of Science:

• Hematology
• Transfusion Medicine
• Biomedical Engineering

Background:

• Platelet transfusions are crucial in modern medicine, but the impact of processing and storage on in vivo function remains unclear.
• Current FDA criteria rely on in vitro measures, necessitating better models to assess in vivo platelet performance.
• Understanding how platelet processing and storage affect transfusion efficacy is vital for improving patient outcomes.

Approach:

• Developed a novel mouse model for platelet transfusion, adhering to FDA criteria.
• Prepared and characterized fresh and stored mouse platelet units, assessing pH, cell counts, and in vitro activation/aggregation.
• Utilized a tail transection assay to evaluate in vivo hemostatic function and confocal imaging to track transfused platelets.

Key Points:

• Fresh and 1-day stored mouse platelets exhibited acceptable quality, including pH, cell counts, and in vitro activation.
• Transfused fresh and 1-day stored platelets demonstrated acceptable post-transfusion recovery and were detected in vivo within clots.
• Platelet units stored for 2 days showed clinically unacceptable quality, indicating limitations in extended storage.

Conclusions:

• Established a mouse model for platelet transfusion analogous to human units, with a maximum recommended storage of 1 day.
• This model serves as a valuable tool for investigating the effects of processing modifications and storage conditions on transfused platelet function in vivo.
• The findings underscore the critical need to optimize platelet processing and storage to ensure in vivo efficacy and safety.